(Q44414175)

English

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells

scientific article published on May 2, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells (English)

1 reference

Europe PubMed Central

2 December 2017

Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells (English)

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

author name string

Petra Augstein

1

1 reference

Europe PubMed Central

2 December 2017

Annemarie Dunger

2

1 reference

Europe PubMed Central

2 December 2017

Peter Heinke

3

1 reference

Europe PubMed Central

2 December 2017

Gerhild Wachlin

4

1 reference

Europe PubMed Central

2 December 2017

Sabine Berg

5

1 reference

Europe PubMed Central

2 December 2017

Bernd Hehmke

6

1 reference

Europe PubMed Central

2 December 2017

Eckhard Salzsieder

7

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

2 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711326

27 December 2023

full work available at URL

https://api.elsevier.com/content/article/PII:S0006291X03005904?httpAccept=text/xml

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

https://api.elsevier.com/content/article/PII:S0006291X03005904?httpAccept=text/plain

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

2 December 2017

304

1 reference

Europe PubMed Central

2 December 2017

2

1 reference

Europe PubMed Central

2 December 2017

378-384

1 reference

Europe PubMed Central

2 December 2017

Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR(gamma) and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Novel insulin sensitizers: pharmacogenomic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones: metabolic actions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Inflammatory status and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR agonists as direct modulators of the vessel wall in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Inflammation and the development of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR and immune system--what do we know?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Troglitazone prevents insulin dependent diabetes in the non-obese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Benign versus destructive insulitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Cellular and molecular changes accompanying the progression from insulitis to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Detection of islet cell specificity of monoclonal islet cell surface antibodies by means of double-staining immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Immunoadsorption of immunoglobulins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Control of islet intercellular adhesion molecule-1 expression by interferon-alpha and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The immunological synapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

The immunological synapse: integrins take the stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

A key role for ICAM-1 in generating effector cells mediating inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Oral DNA vaccination with a plasmid encoding soluble ICAM-1 modulates cytokine expression profiles in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Macrophages and antioxidant status in the NOD mouse pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Myocardial cell death in human diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Avidity regulation of integrins: the driving force in leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Multiple immuno-regulatory defects in type-1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Suppressor T cells--they're back and critical for regulation of autoimmunity!

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Th1 and Th2 cytokines exert regulatory effects upon islet microvascular areas in the NOD mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Insulin therapy of prediabetes suppresses TH1 associated gene expression in BB rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900590-4

7 January 2021

Diabetes research (Edinburgh, Scotland)

39

3

13

author name string

Hehmke

publication date

1986

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

44

42

A156

author name string

Fischer

publication date

1999

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

60

41

A160

author name string

Dunger

publication date

1998

1 reference

10.1016/S0006-291X(03)00590-4

https://api.crossref.org/works/10.1016/S0006-291X(03)00590-4

27 December 2023

Identifiers

10.1016/S0006-291X(03)00590-4

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44414175&oldid=2037961750"